Adverum Biotechnologies · 4 months ago
Work with us!
Redwood City, CA
Full-time
Hybrid
New Grad, Entry LevelAdverum Biotechnologies, Inc. is a clinical-stage company focused on establishing gene therapy as a new standard for treating ocular diseases. They are developing innovative therapies to restore vision and prevent blindness, particularly through their novel gene therapy candidate for age-related macular degeneration.
BiotechnologyPharmaceuticalTherapeutics
Qualification
Company
Adverum Biotechnologies
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.
Founded in 2006
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$814.87MKey Investors
TCG CrossoverVenrock
2025-10-24Acquired
2024-02-05Post Ipo Equity· $127.5M
2020-08-11Post Ipo Equity· $217M
Leadership Team
Romuald Corbau
Chief Scientific Officer
Star Seyedkazemi
Chief Development Officer
Recent News
The Motley Fool
2026-01-16
The Motley Fool
2025-12-24
2025-12-22
Company data provided by crunchbase